Accueil
Explorer
nav.journalClub
Tendances
Plus
synapse
⌘+K
Langue
Français
Français
March 3, 2026
Open Access
The immunological profile of RC17 hESC-derived dopaminergic neural progenitor cells in vitro: Implications for the STEM-PD clinical trial.
JJ
Joanna Jones
AC
Annabel Curle
SF
Shaline Fazal
See all
Key Points
Dopaminergic neural progenitor cells show a distinct immunological profile in vitro, indicating potential implications for treatment.
The study assesses the immunological characteristics of RC17 hESC-derived progenitor cells across various assays, highlighting significant findings.
Analysis of immunological responses utilized in vitro methods to profile neural progenitor cells derived from human embryonic stem cells (hESC).
This work may enable future innovations in treating Parkinson's disease through improved understanding of cell interactions in therapy.
Read Full Paper
externally
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Cite This Study
Copy
Jones et al. (Tue,) studied this question.
synapsesocial.com/papers/69a75ae7c6e9836116a215c5
https://doi.org/https://doi.org/10.17863/cam.125099
Le profil immunologique des cellules progénitrices neuronales dopaminergiques dérivées de hESC RC17 in vitro : Implications pour l'essai clinique STEM-PD. | Synapse